
RTX · NYSE
The supplied consensus is Buy across 22 analysts, with targets ranging from $214 to $235, a $21 spread; the stated mean is $235, equal to the high. Wells Fargo’s David E. Strauss is the most bullish named analyst in the evidence, reaffirming Buy with a $235 target, while Bernstein is least bullish at $214 and Market Perform. No clearly dated analyst action in the supplied material falls within October 26–29. Broader revision signals lean slightly lower: Simply Wall St describes a target adjustment of less than $1 amid recent downgrades, and Bernstein cut its target from $223 on October 15. The disagreement centers on whether RTX’s backlog and exposure to aerospace and defense demand justify its cited 32-times-earnings valuation.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Sanford C. Bernstein | — | $214 | +5.0% | Oct 16, 2026 | Open the report this row came from | |
| Sanford C. Bernstein | — | $214 | +5.0% | Oct 15, 2026 | Open the report this row came from | |
| Deutsche Bank Aktiengesellschaft | — | — | — | Oct 13, 2026 | Open the report this row came from | |
| RBC Capital | — | $235 | +15.3% | Oct 9, 2026 | Open the report this row came from | |
| Sanford C. Bernstein | — | $232 | +13.8% | Aug 3, 2026 | Open the report this row came from |